JAZZ Annual Total Long Term Liabilities
$6.12 B
-$696.66 M-10.22%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual total long term liabilities is $6.12 billion, with the most recent change of -$696.66 million (-10.22%) on December 31, 2023. During the last 3 years, it has risen by +$3.90 billion (+175.36%). JAZZ annual total long term liabilities is now -18.67% below its all-time high of $7.52 billion, reached on December 31, 2021.JAZZ Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly Long Term Liabilities
$7.05 B
+$1.01 B+16.74%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly total long term liabilities is $7.05 billion, with the most recent change of +$1.01 billion (+16.74%) on September 30, 2024. Over the past year, it has increased by +$913.31 million (+14.87%). JAZZ quarterly long term liabilities is now -13.98% below its all-time high of $8.20 billion, reached on June 30, 2021.JAZZ Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.2% | +14.9% |
| 3 y3 years | +175.4% | +14.9% |
| 5 y5 years | +191.3% | +14.9% |
JAZZ Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.7% | at low | -6.2% | +16.7% |
| 5 y | 5-year | -18.7% | +196.6% | -14.0% | +250.9% |
| alltime | all time | -18.7% | >+9999.0% | -14.0% | >+9999.0% |
Jazz Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.05 B(+16.7%) |
| June 2024 | - | $6.04 B(-0.4%) |
| Mar 2024 | - | $6.07 B(-0.8%) |
| Dec 2023 | $6.12 B(-10.2%) | $6.12 B(-0.4%) |
| Sept 2023 | - | $6.14 B(-9.5%) |
| June 2023 | - | $6.79 B(-0.2%) |
| Mar 2023 | - | $6.80 B(-0.2%) |
| Dec 2022 | $6.82 B(-9.4%) | $6.82 B(-0.1%) |
| Sept 2022 | - | $6.83 B(-6.4%) |
| June 2022 | - | $7.29 B(-1.7%) |
| Mar 2022 | - | $7.42 B(-1.3%) |
| Dec 2021 | $7.52 B(+238.6%) | $7.52 B(-3.6%) |
| Sept 2021 | - | $7.80 B(-4.8%) |
| June 2021 | - | $8.20 B(+271.6%) |
| Mar 2021 | - | $2.21 B(-0.7%) |
| Dec 2020 | $2.22 B(+7.7%) | $2.22 B(-2.2%) |
| Sept 2020 | - | $2.27 B(-9.6%) |
| June 2020 | - | $2.51 B(+25.1%) |
| Mar 2020 | - | $2.01 B(-2.6%) |
| Dec 2019 | $2.06 B(-1.8%) | $2.06 B(-0.9%) |
| Sept 2019 | - | $2.08 B(-2.5%) |
| June 2019 | - | $2.14 B(-0.0%) |
| Mar 2019 | - | $2.14 B(+1.7%) |
| Dec 2018 | $2.10 B(-0.8%) | $2.10 B(-0.8%) |
| Sept 2018 | - | $2.12 B(-0.7%) |
| June 2018 | - | $2.13 B(+0.3%) |
| Mar 2018 | - | $2.12 B(+0.4%) |
| Dec 2017 | $2.12 B(-20.6%) | $2.12 B(-6.4%) |
| Sept 2017 | - | $2.26 B(-3.9%) |
| June 2017 | - | $2.35 B(-3.5%) |
| Mar 2017 | - | $2.44 B(-8.5%) |
| Dec 2016 | $2.67 B(+76.8%) | $2.67 B(-10.6%) |
| Sept 2016 | - | $2.98 B(+95.0%) |
| June 2016 | - | $1.53 B(+0.0%) |
| Mar 2016 | - | $1.53 B(+1.4%) |
| Dec 2015 | $1.51 B | $1.51 B(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $1.56 B(-9.3%) |
| June 2015 | - | $1.72 B(+0.6%) |
| Mar 2015 | - | $1.71 B(-2.2%) |
| Dec 2014 | $1.75 B(+137.0%) | $1.75 B(-1.8%) |
| Sept 2014 | - | $1.78 B(+6.3%) |
| June 2014 | - | $1.68 B(-0.8%) |
| Mar 2014 | - | $1.69 B(+129.1%) |
| Dec 2013 | $738.66 M(+13.0%) | $738.66 M(+0.0%) |
| Sept 2013 | - | $738.44 M(+0.6%) |
| June 2013 | - | $734.08 M(+21.5%) |
| Mar 2013 | - | $604.07 M(-7.6%) |
| Dec 2012 | $653.66 M(+8158.5%) | $653.66 M(-1.3%) |
| Sept 2012 | - | $662.04 M(-1.8%) |
| June 2012 | - | $674.17 M(+7437.6%) |
| Mar 2012 | - | $8.94 M(+13.0%) |
| Dec 2011 | $7.92 M(-82.5%) | $7.92 M(-11.6%) |
| Sept 2011 | - | $8.95 M(-14.7%) |
| June 2011 | - | $10.50 M(-67.9%) |
| Mar 2011 | - | $32.66 M(-27.8%) |
| Dec 2010 | $45.24 M(-62.6%) | $45.24 M(-21.0%) |
| June 2010 | - | $57.28 M(-45.9%) |
| Mar 2010 | - | $105.79 M(-12.6%) |
| Dec 2009 | $120.98 M(+228.0%) | $120.98 M(-17.4%) |
| Sept 2009 | - | $146.50 M(-0.5%) |
| June 2009 | - | $147.26 M(+336.9%) |
| Mar 2009 | - | $33.70 M(-8.6%) |
| Dec 2008 | $36.88 M(-68.1%) | $36.88 M(-75.7%) |
| Sept 2008 | - | $151.53 M(-0.2%) |
| June 2008 | - | $151.91 M(+0.0%) |
| Mar 2008 | - | $151.85 M(+31.2%) |
| Dec 2007 | $115.71 M(-67.9%) | $115.71 M(-0.0%) |
| Sept 2007 | - | $115.72 M(-0.4%) |
| June 2007 | - | $116.17 M(+14.9%) |
| Mar 2007 | - | $101.09 M(-71.9%) |
| Dec 2006 | $360.35 M(+38.8%) | $360.35 M(+38.8%) |
| Dec 2005 | $259.69 M | $259.69 M |
FAQ
- What is Jazz Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Jazz Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Jazz Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of JAZZ is $6.12 B
What is the all time high annual total long term liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total long term liabilities is $7.52 B
What is Jazz Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, JAZZ annual total long term liabilities has changed by -$696.66 M (-10.22%)
What is Jazz Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of JAZZ is $7.05 B
What is the all time high quarterly long term liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total long term liabilities is $8.20 B
What is Jazz Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, JAZZ quarterly total long term liabilities has changed by +$913.31 M (+14.87%)